ION Television to Air Award-Winning Series Weeknights This Fall

ION Media Networks Secures Rights to Critically-Acclaimed Series from Twentieth Television

Public Television Veteran to Spearhead Regulatory Policy, as Well as Digital and Mobile Television Strategy and Development

Reserve Stock Split Will Complete Going Private Process

Television Industry Veteran Brings Extensive Experience in Brand Strategy and Marketing

The India-based company Veeda Clinical Research continued its acquisitive ways by buying International Oncology Network (ION), a clinical research company with 50 clinical trial sites across the US. ION, headquartered in Texas, was part of Amerisource Bergen. The purchase price was not disclosed. ION will become part of the cancer subsidiary of Veeda, known as Veeda Oncology. Veeda has been active recently in acquisitions. More details...

Stock Symbols: (NYSE: LLY) (NYSE: DNA) (NYSE: SNY) (NYSE: BMY) (NYSE: WX)

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=2202578 for the full story.

As early as August of last year Jen-Hsun Huang, NVIDIA’s CEO, said of netbooks, “that’s just not our target. I mean, there are a lot of things that are not our targets and that just happens to be one of the things that is not our target” (Earnings Call Transcript). That was then. This is now. [...]